ationwide registry for needle tract seeding after endoscopic ultrasound-guided fine needle aspiration in pancreatic tumors
Not Applicable
Recruiting
- Conditions
- pancreatic tumor
- Registration Number
- JPRN-UMIN000052674
- Lead Sponsor
- Wakayama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2900
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with blood vessels or other tumors in the puncture route on various imaging examinations performed prior to enrollment Patients with bleeding tendency (PT INR > 1.5 or Plt < 50000 micro L) Patients in whom antithrombotic drugs cannot be discontinued Patients in whom the tumor cannot be visualized by EUS due to a history of gastrectomy, etc. Patients with clear distant metastasis at the time of puncture or patients with pancreatic tumors which can be judged to be unresectable Patients who are deemed inappropriate as subjects by the investigator (subinvestigator)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of needle tract seeding after EUS-FNA in patients receiving surgical resection of pancreatic tumors
- Secondary Outcome Measures
Name Time Method Incidence of needle tract seeding after EUS-FNA in patients with resected pancreatic ductal carcinomas Incidence of needle tract seeding after EUS-FNA in patients with resected pancreatic tumors other than ductal carcinomas Factors associated with incidence of needle tract seeding after EUS-FNA The time from EUS-FNA to the manifestation of needle tract seeding, size of NTS lesion, location of NTS lesion, and whether the tumor was resected or not Prognosis of patients with needle tract seeding after EUS-FNA Prognostic factors of needle tract seeding after EUS-FNA Pathological examinations of resected NTS lesions